BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,779,978 | -19.1% | 285,638 | -2.3% | 0.04% | -14.0% |
| Q2 2023 | $13,317,690 | +11.9% | 292,311 | -0.3% | 0.05% | +6.4% |
| Q1 2023 | $11,896,248 | -19.5% | 293,300 | +1.1% | 0.05% | -25.4% |
| Q4 2022 | $14,780,077 | -11.3% | 289,976 | -6.2% | 0.06% | -11.3% |
| Q3 2022 | $16,658,000 | -14.7% | 309,286 | +1.7% | 0.07% | -12.3% |
| Q2 2022 | $19,533,000 | -16.3% | 304,107 | +1.0% | 0.08% | +1.2% |
| Q1 2022 | $23,344,000 | -9.5% | 301,055 | +0.2% | 0.08% | -3.6% |
| Q4 2021 | $25,793,000 | +4.3% | 300,475 | -2.3% | 0.08% | -3.5% |
| Q3 2021 | $24,741,000 | -4.2% | 307,610 | -4.1% | 0.09% | -2.3% |
| Q2 2021 | $25,822,000 | -9.8% | 320,772 | -5.5% | 0.09% | -13.7% |
| Q1 2021 | $28,620,000 | -3.3% | 339,347 | -8.0% | 0.10% | -3.8% |
| Q4 2020 | $29,606,000 | -2.5% | 368,975 | -2.3% | 0.11% | -11.7% |
| Q3 2020 | $30,370,000 | -14.6% | 377,638 | -8.6% | 0.12% | -16.7% |
| Q2 2020 | $35,582,000 | +0.2% | 413,270 | -5.5% | 0.14% | -12.7% |
| Q1 2020 | $35,514,000 | -1.4% | 437,421 | +1.6% | 0.16% | +21.3% |
| Q4 2019 | $36,003,000 | -4.3% | 430,557 | +0.1% | 0.14% | -11.7% |
| Q3 2019 | $37,638,000 | +15.0% | 430,292 | +7.6% | 0.15% | +13.2% |
| Q2 2019 | $32,742,000 | +6.8% | 399,776 | -0.4% | 0.14% | +7.1% |
| Q1 2019 | $30,668,000 | +13.3% | 401,309 | -2.4% | 0.13% | -3.8% |
| Q4 2018 | $27,057,000 | -14.8% | 411,061 | -0.2% | 0.13% | 0.0% |
| Q3 2018 | $31,740,000 | +2.8% | 411,730 | -1.6% | 0.13% | -1.5% |
| Q2 2018 | $30,887,000 | +12.0% | 418,302 | -1.3% | 0.13% | +8.9% |
| Q1 2018 | $27,567,000 | -2.9% | 423,852 | -3.5% | 0.12% | +0.8% |
| Q4 2017 | $28,397,000 | -1.3% | 439,320 | -4.2% | 0.12% | -6.2% |
| Q3 2017 | $28,766,000 | +7.5% | 458,418 | +3.8% | 0.13% | +1.6% |
| Q2 2017 | $26,747,000 | +17.2% | 441,810 | +0.4% | 0.13% | +14.3% |
| Q1 2017 | $22,831,000 | +19.6% | 440,228 | +2.2% | 0.11% | +10.9% |
| Q4 2016 | $19,094,000 | -6.6% | 430,606 | +0.2% | 0.10% | -9.8% |
| Q3 2016 | $20,449,000 | -8.1% | 429,601 | -12.7% | 0.11% | -9.7% |
| Q2 2016 | $22,261,000 | +8.7% | 492,279 | -1.2% | 0.12% | +6.0% |
| Q1 2016 | $20,471,000 | +9.8% | 498,330 | +1.9% | 0.12% | +7.3% |
| Q4 2015 | $18,651,000 | +17.0% | 488,909 | +0.7% | 0.11% | +9.0% |
| Q3 2015 | $15,945,000 | -52.0% | 485,394 | +2.1% | 0.10% | -49.7% |
| Q2 2015 | $33,230,000 | +3.2% | 475,189 | +1.1% | 0.20% | +2.6% |
| Q1 2015 | $32,206,000 | -3.2% | 470,161 | +3.6% | 0.19% | -6.7% |
| Q4 2014 | $33,258,000 | +1.2% | 453,790 | -0.9% | 0.21% | -2.3% |
| Q3 2014 | $32,851,000 | +7.5% | 457,714 | +8.3% | 0.21% | 0.0% |
| Q2 2014 | $30,557,000 | -4.2% | 422,645 | -2.5% | 0.21% | -7.0% |
| Q1 2014 | $31,909,000 | +6.2% | 433,672 | +0.4% | 0.23% | +4.1% |
| Q4 2013 | $30,038,000 | +7.2% | 431,898 | +1.2% | 0.22% | -3.9% |
| Q3 2013 | $28,033,000 | +969.1% | 426,746 | +1027.6% | 0.23% | -59.6% |
| Q2 2013 | $2,622,000 | – | 37,847 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |